Recent Headlines
YD Diagnostics CORP. Launches the New Fully Automated Liquid Based Cytology Solutions
YD Diagnostics CORP. a leading developer, manufacturer and supplier of innovative diagnostics products dedicated to serving the healthcare of humans, announced today the launching of the new fully automated system for liquid based cytology solution for both Gyn and Non-Gyn. - July 03, 2014 - YD Diagnostics CORP.
Within3 Partners with Ashfield Healthcare Communications
Within3 has announced a partnership with Ashfield Healthcare Communications to provide an enhanced suite of services for both organizations. - June 22, 2014 - Within3
Life Science Strategy Group Launches the OutsourcePharma Advisory Board
Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC
Within3 Partners with DHC for Better Healthcare Solutions
Within3 has announced its partnership with the Digital Health Coalition (DHC). This strategic partnership creates business value for both organizations. - May 08, 2014 - Within3
Epitope Diagnostics, Inc. Expands Product Panel with New Set of H. Pylori Antigen ELISA Kits and Novel Sample Collection Device
Epitope Diagnostics, Inc. has launched two user-friendly fecal Helicobacter pylori (H. pylori) antigen ELISA kits, along with a new sample collection device. One ELISA assay is qualitative while the other is quantitative, allowing for both the detection and measurement of active H. pylori antigen. H. pylori is a bacterium which causes infectious stomach disease and is linked to stomach cancer. A positive H. pylori antigen test indicates an active infection. - April 22, 2014 - Epitope Diagnostics, Inc.
ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube
ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014 - ALPCO
ALPCO Releases STELLUX™ Chemiluminescent Human Intact Proinsulin ELISA
ALPCO has launched their new STELLUX™ Chemi Human Intact Proinsulin ELISA, the latest addition to their chemiluminescent product line. - February 18, 2014 - ALPCO
SFL Experts to Present and Chair Sessions at the 2014 DIA Annual Euromeeting in Vienna
SFL experts will present on EU medical device/IVD law, public & regulatory affairs synergies and transparency of payments to the healthcare sector at 2014 DIA Annual EuroMeeting. - February 12, 2014 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO's New FDA Cleared 25-OH Vitamin D Total ELISA Provides Option for Hospitals and Smaller Clinical Labs to Bring Affordable Testing In-House
ALPCO expands test portfolio for clinical and hospital laboratory customers with the release of a FDA 510(k) cleared 25-OH Vitamin D Total ELISA. - January 22, 2014 - ALPCO
SFL Managing Director Provides Further Update Regarding Revision of EU Medtech Legislation
SFL’s Managing Director, Shayesteh Fürst-Ladani will be giving presentations at two upcoming Swiss life science events on revision of EU Medtech legislation. - November 21, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO Releases STELLUX™ Chemiluminescence Human Total Proinsulin ELISA
A new Human Total Proinsulin ELISA is launched in ALPCO's STELLUX™ Chemiluminescent line of assays. - November 19, 2013 - ALPCO
SFL’s Managing Director to Give Presentation at Informa’s 8th Annual Drug Device Combination Products Event in Berlin
SFL’s Managing Director provides regulatory insight into Drug Device Combination Products in Europe. - November 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO Expands Product Offering with Addition of Mouse-Specific Flow Cytometry Reagents
Earlier this year, ALPCO began offering flow cytometry reagents and data analysis software. As promised, the company has recently added high quality and affordable mouse reagents to their growing flow cytometry portfolio. Among the 600 new mouse reagents are antibodies for CD3, CD4, CD8 and... - October 29, 2013 - ALPCO
ALPCO Launches STELLUX™ Chemiluminescent Human Insulin ELISA
ALPCO releases second chemiluminescent assay in STELLUX™ product line. - October 24, 2013 - ALPCO
Epitope Diagnostics Launches the Second Generation Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate (ADC) Levels
Epitope Diagnostics has recently launched second-generation ADC kits exclusively for the quantitative measurement of DM1-, MMAE-, and MMAF-ADC level. These kits measure both humanized monoclonal antibody based ADC and mouse monoclonal antibody based ADC. Additional benefits for testing PK samples from mice are utilized by these second generation kits. - October 12, 2013 - Epitope Diagnostics, Inc.
The Changing Environment for Pharma and Medtech Companies in Europe
SFL Regulatory Affairs Consulting Ltd. (SFL) is pleased to be strengthening its activities in the UK and will be holding an inaugural and networking event in London on 8 October 2013. - September 30, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event
SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
New Research Validates Importance of Central Lab to Overall Investigator Satisfaction
More than 250 Clinical Investigators Indicate Central Lab Preference - July 26, 2013 - Life Science Strategy Group, LLC
Epitope Diagnostics Launches the First Commercially Available Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate Level (ADC)
Epitope Diagnostics has proudly introduced immunoassay kits exclusively for the quantitative measurement of antibody drug conjugate level (ADC). These kits include the EDI™ Mertansine (DM1) ADC EIA Kit, EDI™ Monomethylauristatin F (MMAF) ADC EIA Kit, and the EDI™ Monomethylauristatin E (MMAE) ADC EIA Kit. This technology, together with groundbreaking applications such as Genentech's Kadcyla (Ado-Trastuzumab Emtansine), this promising approach may help to clinically monitor cancer treatment. - June 20, 2013 - Epitope Diagnostics, Inc.
ALPCO to Distribute NAG Assays from PPR Diagnostics
New distribution agreement allows ALPCO to distribute NAG assays from PPR Diagnostics. - June 13, 2013 - ALPCO
Mouse Osteopontin ELISA Now Available from ALPCO
ALPCO launches the second species-specific kit in a line of Osteopontin ELISAs. - May 31, 2013 - ALPCO
The EDI Human Intact FGF-21 ELISA Kit is the First Immunoassay Kit That Exclusively Measures Human Intact FGF-21
Epitope Diagnostics is pleased to introduce a brand new ELISA kit for the quantitative determination of β-Klotho & FGF Receptor Active Human Intact FGF-21 level in EDTA-plasma or serum. This assay measures human intact FGF-21, instead of FGF-21 fragments like similar commercially available kits on the market today. - May 31, 2013 - Epitope Diagnostics, Inc.
ALPCO to Exhibit with BÜHLMANN Laboratories at DDW 2013 and Feature Fecal Calprotectin ELISA
The partnering companies will feature BÜHLMANN's Fecal Calprotectin ELISA that is pending FDA clearance for IVD use in the United States. - May 16, 2013 - ALPCO
ALPCO Adds FDA Registered Renin RIA from Cisbio to Product Offering
ALPCO now offering a line of RIA products from Cisbio in the United States. - May 07, 2013 - ALPCO
ALPCO Launches Human Osteopontin ELISA
ALPCO launches the first assay in a new line of species-specific Osteopontin ELISAs. - May 01, 2013 - ALPCO
ALPCO Expands Product Offering with EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analytical Software from Cytognos S.L.
Starting April 30, 2013 ALPCO will begin offering flow cytometry solutions from Cytognos S.L. - April 30, 2013 - ALPCO
ALPCO Launches Their First STELLUX Chemiluminescent ELISA
ALPCO announces the launch of their STELLUX Rodent Insulin ELISA, the first ELISA launched in their new STELLUX Chemiluminescent assay product line. - April 26, 2013 - ALPCO
ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents
After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013 - ALPCO
SFL Appoints Advisory Board
SFL announces details of its Advisory Board. - March 22, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Experts to Present and Chair Sessions at the 2013 DIA Annual EuroMeeting
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at DIA EuroMeeting in Amsterdam. - March 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
GHMI Partners with AnalizaDx to Bring Advanced Cancer Diagnostics to Africa
Simple blood-based cancer diagnostics and screening tests to enable early and effective treatment while reducing unnecessary procedures - February 27, 2013 - GHMI
GenScript Upgrade Free Bioinformatics Tools
GenScript provides a comprehensive range of online bioinformatics tools for Molecular Biology, Peptide, and Protein Researchers，as well as many other common bioinformatics tools. - February 23, 2013 - GenScript USA Inc.
SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013. - February 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Launches eBlot® Protein Transfer System
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers. - February 07, 2013 - GenScript USA Inc.
GenScript Launches New PolyExpress Package
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods. - February 03, 2013 - GenScript USA Inc.
ProteinSignal - A New Brand of GenScript, Focused on Protein Research
ProteinSignal will serve as a pioneering developer and supplier of high performance protein research products covering the entire protein analysis workflow. Their offerings include cytokines and growth factors, protein purification resins, precast PAGE gels, protein standards, gel staining systems, anti-tag antibodies, western blot detection, ELISA kits and endotoxin detection and removal kits. - January 27, 2013 - GenScript USA Inc.
2012 - An Award-Winning Year for SFL
This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
General Biologicals Corporation Signs ALPCO as a Distributor in North America
ALPCO will distribute Infectious Disease assays from GBC in North America. - December 18, 2012 - ALPCO
ALPCO Diagnostics Recognized in Support of American Red Cross’ Hurricane Sandy Relief Efforts
ALPCO presented with plaque of recognition for their contribution to the American Red Cross' Hurricane Sandy Relief Fund. - December 12, 2012 - ALPCO
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012 - ALPCO
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012 - ALPCO
SFL Selected as Finalist in the British-Swiss Business Awards
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is proud to announce that the company has been selected as a finalist in the second annual British-Swiss Business Awards. - October 13, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO’s Mouse Sclerostin ELISA to be Featured at ASBMR
A collaboration between ALPCO Diagnostics and the Mayo Clinic has yielded a poster that will be presented at this year’s ASBMR meeting in Minneapolis, MN. - October 04, 2012 - ALPCO
SFL’s Managing Director Invited to Speak at World Medtech Forum
Shayesteh Fürst-Ladani, Managing Director of the SFL will speak on European Day at the World Medtech Forum in Lucerne, Switzerland. - September 22, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL’s Managing Director and Head of UK Office to Speak at DIA Combination Products Workshop in Basel, Switzerland
SFL’s team to provide delegates with an understanding of the regulatory framework for drug/device combinations and drug/companion diagnostics in the EU. - September 08, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO Adds an FDA Registered ELISA for West Nile Virus
ALPCO announces the addition of two FDA Registered ELISAs for the measurement of West Nile Virus. - September 05, 2012 - ALPCO
SFL’s Managing Director Receives Open University Business School’s Alumni Award for Outstanding Contribution to an Organisation 2012
The Open University Business School Alumni Network nominates and elects individuals that demonstrate best the application of learnings from the Open University MBA training and achievement of outstanding results. - July 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO Diagnostics Launches Mouse Sclerostin ELISA
ALPCO Diagnostics announces the launch of an ELISA specific for measuring mouse sclerostin in serum and plasma. - July 10, 2012 - ALPCO
SFL’s Managing Director Invited to Chair Session and Speak at DIA 48th Annual Meeting in Philadelphia
SFL's Managing Director updates DIA attendees on Revision of European Medical Device Directives. - June 27, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
ALPCO & Argutus Medical Collaboration
Kidney & Liver Toxicity Gold Standard Rat Alpha GST ELISA Available Once Again - June 26, 2012 - ALPCO